2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
ACC/AHA Representative.
Glenn N
GN
Levine
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Eric R
ER
Bates
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|SCAI Representative.
James C
JC
Blankenship
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|SCAI Representative.
Steven R
SR
Bailey
ACC/AHA Representative.
John A
JA
Bittl
ACC/AHA Representative.
Bojan
B
Cercek
SCAI Representative.
Charles E
CE
Chambers
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Stephen G
SG
Ellis
ACC/AHA Task Force on Clinical Practice Guidelines Liaison.
Robert A
RA
Guyton
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Steven M
SM
Hollenberg
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Umesh N
UN
Khot
ACC/AHA Representative.
Richard A
RA
Lange
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Laura
L
Mauri
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|SCAI Representative.
Roxana
R
Mehran
SCAI Representative.
Issam D
ID
Moussa
ACC/AHA Representative.
Debabrata
D
Mukherjee
ACC/AHA Representative.
Henry H
HH
Ting
ACC/AHA Representative.
Patrick T
PT
O'Gara
ACC/AHA Representative.
Frederick G
FG
Kushner
Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 2015, after the writing effort was completed. In accordance with ACC/AHA policy, she recused herself from the final voting process.
Deborah D
DD
Ascheim
ACC/AHA Task Force on Clinical Practice Guidelines Liaison.
Ralph G
RG
Brindis
ACP Representative.
Donald E
DE
Casey
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Mina K
MK
Chung
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
James A
JA
de Lemos
ACEP Representative.
Deborah B
DB
Diercks
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
James C
JC
Fang
ACC/AHA Representative.
Barry A
BA
Franklin
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Christopher B
CB
Granger
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Harlan M
HM
Krumholz
ACC/AHA Representative.
Jane A
JA
Linderbaum
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
David A
DA
Morrow
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
L
L
Kristin Newby
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
Joseph P
JP
Ornato
ACC/AHA Representative.
Narith
N
Ou
ACC/AHA Representative.
Martha J
MJ
Radford
ACC/AHA Representative.
Jacqueline E
JE
Tamis-Holland
SCAI Representative.
Carl L
CL
Tommaso
ACC/AHA Representative.
Cynthia M
CM
Tracy
ACC/AHA Representative.
Y
Y
Joseph Woo
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.|ACC/AHA Representative.
David X
DX
Zhao
Jonathan L
JL
Halperin
Glenn N
GN
Levine
Former Task Force member; current member during the writing effort.
Jeffrey L
JL
Anderson
Former Task Force member; current member during the writing effort.
Nancy M
NM
Albert
Sana M
SM
Al-Khatib
Kim K
KK
Birtcher
Biykem
B
Bozkurt
Ralph G
RG
Brindis
Joaquin E
JE
Cigarroa
Lesley H
LH
Curtis
Lee A
LA
Fleisher
Federico
F
Gentile
Samuel
S
Gidding
Mark A
MA
Hlatky
John
J
Ikonomidis
Jose
J
Joglar
Former Task Force member; current member during the writing effort.
Richard J
RJ
Kovacs
Former Task Force member; current member during the writing effort.
E
E
Magnus Ohman
Susan J
SJ
Pressler
Former Task Force member; current member during the writing effort.
Frank W
FW
Sellke
Former Task Force member; current member during the writing effort.
Win-Kuang
WK
Shen
Duminda N
DN
Wijeysundera
D000572:American Heart Association; D002309:Cardiology / Q000592:standards*; D017023:Coronary Angiography / Q000592:standards*; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000592:standards*; D000072657:ST Elevation Myocardial Infarction / Q000175:diagnosis* / Q000601:surgery*; D012955:Societies, Medical; D014481:United States
ACC/AHA Clinical Practice Guideline; culprit vessel; focused update; multivessel; myocardial infarction; primary PCI; thrombectomy